CNS Co.,Ltd. (4076) AI Stock Analysis

• Market Cap: ¥4.34B
• Dividend Yield: 5.02%
• Average Volume (3M): 4.80K
• Price to Earnings (P/E): 10.2
• Beta (1Y): 0.37
• Revenue Growth: 3.98%
• EPS Growth: -12.31%
• Country: JP
• Employees: 255
• Sector: Technology
• Sector Strength: 95
• Industry: Information Technology Services
• EPS (TTM): 43.97
• Shares Outstanding: 2,906,000
• 10 Day Avg. Volume: 4,690
• 30 Day Avg. Volume: 4,796
• PEG Ratio: 0.78
• Price to Book (P/B): 1.11
• Price to Sales (P/S): 0.00
• P/FCF Ratio: 0.00
• Enterprise Value/Market Cap: N/A
• Enterprise Value/Revenue: N/A
• Enterprise Value/Gross Profit: N/A
• Enterprise Value/Ebitda: N/A
• 1Y Price Target: ¥1,742.00
• Price Target Upside: 16.52% Upside
• Rating Consensus: Moderate Buy
• Number of Analyst Covering: 0

• Rating: 72 Outperform
• Price Target: ¥1,668.00 ▲(11.57%Upside)

CNS Co.,Ltd. is bolstered by strong financial performance, characterized by robust revenue growth and excellent cash flow ratios. Despite this, technical indicators suggest bearish momentum, which may pose a short-term risk. The valuation remains attractive with a reasonable P/E ratio and a high dividend yield, balancing the score between the company's financial strength and current market conditions.

CNS Co.,Ltd. Business Overview & Revenue Model

Company Description

CNS Co., Ltd. (4076) is a company engaged in the technology and electronics sectors, focusing on developing and providing cutting-edge solutions and products. The company specializes in creating innovative systems and devices that cater to various industries, including telecommunications, consumer electronics, and industrial applications.

How the Company Makes Money

CNS Co., Ltd. generates revenue through the sale of its technology products and services. The company's primary revenue streams include the manufacturing and distribution of electronic components and systems for telecommunications and industrial applications, as well as consumer electronics. CNS Co., Ltd. may also engage in strategic partnerships and collaborations with other businesses to enhance its market reach and develop new technologies, contributing to its overall earnings.

CNS Co.,Ltd. Financial Statement Overview

Summary

CNS Co.,Ltd. demonstrates impressive financial health with consistent revenue growth, strong profitability margins, and a robust balance sheet. The company maintains minimal leverage, high returns on equity, and excellent cash flow ratios, positioning it well for future growth and stability.

Income Statement

CNS Co.,Ltd. exhibits strong income statement performance with consistent revenue growth, achieving a 11.15% increase in the latest year. Gross profit margin remains robust at 24.62%, indicating effective cost management. The net profit margin improved to 6.93%, reflecting efficiency in operations. EBIT and EBITDA margins are healthy, at 9.31% and 10.08% respectively, supporting profitability.

Balance Sheet

The company's balance sheet is solid with a low debt-to-equity ratio of 0.003, showcasing minimal leverage and financial risk. The return on equity is strong at 12.56%, indicating effective use of equity capital. The equity ratio stands at 74.42%, underscoring a strong equity base relative to total assets, enhancing financial stability.

Cash Flow

CNS Co.,Ltd. demonstrates positive cash flow dynamics with significant free cash flow growth of 88.45% year-on-year. The operating cash flow to net income ratio is healthy at 1.22, indicating strong cash generation relative to profitability. The free cash flow to net income ratio is excellent at 1.20, supporting liquidity and potential for reinvestment.

Breakdown	Jun 2024	Jun 2023	Jun 2022	Jun 2021	Jun 2020
Income Statement
Total Revenue	6.66B	5.99B	5.42B	4.84B	4.58B
Gross Profit	1.64B	1.51B	1.32B	1.15B	973.47M
EBITDA	671.18M	619.28M	620.28M	503.30M	498.12M
Net Income	461.33M	433.10M	409.49M	336.71M	325.31M
Balance Sheet
Total Assets	4.93B	4.55B	4.15B	3.14B	2.80B
Cash, Cash Equivalents and Short-Term Investments	3.57B	3.16B	3.01B	1.88B	1.56B
Total Debt	10.65M	13.40M	5.65M	7.01M	8.33M
Total Liabilities	1.26B	1.21B	1.11B	1.14B	1.08B
Stockholders Equity	3.67B	3.34B	3.04B	1.99B	1.72B
Cash Flow
Free Cash Flow	553.82M	293.94M	442.91M	125.44M	627.91M
Operating Cash Flow	564.57M	352.80M	461.45M	183.12M	646.28M
Investing Cash Flow	-80.65M	-125.97M	-23.01M	135.29M	11.54M
Financing Cash Flow	-133.52M	-132.92M	633.75M	-64.02M	-151.45M

CNS Co.,Ltd. Technical Analysis

• Technical Analysis Sentiment: Positive
• Last Price: 1495.00
• 50DMA: Negative
• 100DMA: Positive
• 200DMA: Positive
• MACD: Negative
• RSI: Neutral
• STOCH: Neutral

Evaluating momentum and price trends is crucial in stock analysis to make informed investment decisions. For JP:4076, the sentiment is Positive. The current price of 1495 is above the 20-day moving average (MA) of 1486.15, below the 50-day MA of 1521.35, and above the 200-day MA of 1416.26, indicating a neutral trend. The MACD of -8.71 indicates Negative momentum. The RSI at 50.48 is Neutral, neither overbought nor oversold. The STOCH value of 65.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Positive sentiment for JP:4076.

CNS Co.,Ltd. Peers Comparison

Name	Overall Rating	Market Cap	P/E Ratio	ROE	Dividend Yield	Revenue Growth	EPS Growth
3920	81 Outperform	¥5.49B	12.87		1.02%	13.25%	16826.25%
3839	77 Outperform	¥4.92B	20.49		1.66%	10.32%	-2.85%
4076	72 Outperform	¥4.34B	10.15		5.02%	3.98%	-12.31%
6942	65 Neutral	¥5.49B	52.20		―	-5.20%	133.74%
Sector *	57 Neutral	HK$14.05B	5.48	-5.77%	5.19%	9.65%	-43.80%
3997	51 Neutral	¥4.98B	―		1.55%	15.59%	32.56%
2375	44 Neutral	¥5.00B	―		0.42%	-9.76%	3.53%